Skip to main content

Summary of October 2023 Drug Utilization Review Board Meeting Now Available

Last updated on

The Texas Drug Utilization Review (DUR) Board met on Thursday, October 12, and Friday October 31, 2023, to recommend Medicaid clinical prior authorizations. A summary of this meeting(link is external) is now available from the Texas Health and Human Services Commission (HHSC) Vendor Drug Program(link is external) (VDP) website.

Clinical Prior Authorization Reminders

The following reminders concern clinical prior authorizations:

Preferred Drug List Reminders

The following reminders concern the preferred drug list (PDL):

  • The board did not review the PDL at this meeting. HHSC will incorporate the approved decisions from October 2023 board meetings into the January 2024 PDL.
  • Prescribing providers must use the Medicaid formulary(link is external) and PDL.
  • MCOs must adhere to the Medicaid formulary(link is external) and PDL.
  • Providers should evaluate a drug’s formulary status before its preferred status.

About the Texas DUR Board

Board members meet quarterly in Austin to recommend outpatient prescription drugs for the Medicaid program. A schedule of upcoming meetings, instructions on submitting written materials to the board, and directions about publicly testifying in front of the board are available on the VDP website.

Email vdp-advisory@hhsc.state.tx.us(link sends email) with comments or questions.